2 Stocks Down 17% and 21% to Buy Right Now

One way to earn above-average market returns -- which isn't always easy -- is to invest in companies that have lagged the market but are likely to recover over the long run. As the basic investing maxim goes, "Buy low, sell high."That brings us to DexCom (NASDAQ: DXCM) and Regeneron Pharmaceuticals (NASDAQ: REGN), two healthcare leaders whose shares are down by 17% and 21% this year, respectively. Both have encountered company-specific issues, but despite the roadblocks, they appear to be attractive long-term bets. Here is why.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool